Home LiteratureArticle Details
PMID: 9891053 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.

Molecular and cellular biology ·Vol. 19 ·No. 2 ·1999-02-00 ·Pages 1190-201

Nguyen H, Gitig DM, Koff A

Abstract

Entry into S phase is dependent on the coordinated activation of CDK4,6 and CDK2 kinases. Once a cell commits to S phase, there must be a mechanism to ensure the irreversibility of this decision. The activity of these kinases is inhibited by their association with p27. In many cells, p27 plays a major role in the withdrawal from the cell cycle in response to environmental cues. Thus, it is likely that p27 is a target of the machinery required to ensure the irreversibility of S-phase entry. We have been interested in understanding the mechanisms regulating p27 at the G1/S transition. In this report, we define a cell-free degradation system which faithfully recapitulates the cell cycle phase-specific degradation of p27. We show that this reaction is dependent on active CDK2 activity, suggesting that CDK2 activity is directly required for p27 degradation. In addition to CDK2, other S-phase-specific factors are required for p27 degradation. At least some of these factors are ubiquitin and proteasome dependent. We discuss the relationships between CDK2 activity, ubiquitin-dependent, and possibly ubiquitin-independent proteasomal activities in S-phase extracts as related to p27.

MeSH Terms
Base Sequence CDC2-CDC28 Kinases Cell Cycle Cell Cycle Proteins Cell-Free System Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases/antagonists & inhibitors,metabolism Cyclins/metabolism Cysteine Endopeptidases/metabolism Enzyme Inhibitors/pharmacology G1 Phase HeLa Cells Humans In Vitro Techniques Microtubule-Associated Proteins/genetics,metabolism Multienzyme Complexes/metabolism Oligonucleotide Probes/genetics Proteasome Endopeptidase Complex Protein Serine-Threonine Kinases/antagonists & inhibitors,metabolism Recombinant Proteins/genetics,metabolism S Phase Tumor Suppressor Proteins Ubiquitins/metabolism
Chemicals
Cell Cycle Proteins Cyclins Enzyme Inhibitors Microtubule-Associated Proteins Multienzyme Complexes Oligonucleotide Probes Recombinant Proteins Tumor Suppressor Proteins Ubiquitins Cyclin-Dependent Kinase Inhibitor p27 Protein Serine-Threonine Kinases CDC2-CDC28 Kinases CDK2 protein, human Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinases Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nguyen H
Program in Molecular Biology and Cell Biology and Genetics, Cornell University Graduate School of Medical Sciences, New York, New York 10021, USA.
Gitig D M
Koff A
References (68)
68 references, click to expand
  1. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination.
    Nature. 1992 Dec 10;360(6404):597-9 PMID: 1334232
  2. The ubiquitin-conjugation system.
    Annu Rev Genet. 1992;26:179-207 PMID: 1336336
  3. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.
    Science. 1992 Sep 18;257(5077):1689-94 PMID: 1388288
  4. Activation of human cyclin-dependent kinases in vitro.
    Mol Biol Cell. 1992 May;3(5):571-82 PMID: 1535244
  5. Methylated ubiquitin inhibits cyclin degradation in clam embryo extracts.
    J Biol Chem. 1991 Sep 5;266(25):16376-9 PMID: 1653232
  6. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.
    Cell. 1991 Sep 20;66(6):1217-28 PMID: 1833068
  7. Cyclin is degraded by the ubiquitin pathway.
    Nature. 1991 Jan 10;349(6305):132-8 PMID: 1846030
  8. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.
    Science. 1989 Mar 24;243(4898):1576-83 PMID: 2538923
  9. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2.
    Cell. 1989 Sep 8;58(5):833-46 PMID: 2570636
  10. The yeast cell cycle gene CDC34 encodes a ubiquitin-conjugating enzyme.
    Science. 1988 Sep 9;241(4871):1331-5 PMID: 2842867
  11. Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.
    Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10187-91 PMID: 7479751
  12. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
  13. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B.
    Cell. 1995 Apr 21;81(2):279-88 PMID: 7736580
  14. Degradation of ornithine decarboxylase by the mammalian and yeast 26S proteasome complexes requires all the components of the protease.
    Eur J Biochem. 1995 Apr 1;229(1):276-83 PMID: 7744041
  15. Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome.
    J Biol Chem. 1995 May 12;270(19):11623-7 PMID: 7744802
  16. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
    Nature. 1995 May 11;375(6527):159-61 PMID: 7753174
  17. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Genes Dev. 1995 May 15;9(10):1149-63 PMID: 7758941
  18. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.
    Mol Biol Cell. 1995 Feb;6(2):185-97 PMID: 7787245
  19. p34Cdc28-mediated control of Cln3 cyclin degradation.
    Mol Cell Biol. 1995 Feb;15(2):731-41 PMID: 7823941
  20. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway.
    EMBO J. 1995 Jan 16;14(2):303-12 PMID: 7835341
  21. The ubiquitin-proteasome proteolytic pathway.
    Cell. 1994 Oct 7;79(1):13-21 PMID: 7923371
  22. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.
    Cell. 1994 Oct 21;79(2):233-44 PMID: 7954792
  23. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  24. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
    Genes Dev. 1994 Jan;8(1):9-22 PMID: 8288131
  25. CLB5 and CLB6, a new pair of B cyclins involved in DNA replication in Saccharomyces cerevisiae.
    Genes Dev. 1993 Jul;7(7A):1160-75 PMID: 8319908
  26. Changes in intracellular localization of proteasomes in immortalized ovarian granulosa cells during mitosis associated with a role in cell cycle control.
    Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):99-103 PMID: 8380501
  27. Novel multiubiquitin chain linkages catalyzed by the conjugating enzymes E2EPF and RAD6 are recognized by 26 S proteasome subunit 5.
    J Biol Chem. 1996 Feb 2;271(5):2823-31 PMID: 8576261
  28. Translational control of p27Kip1 accumulation during the cell cycle.
    Science. 1996 Mar 29;271(5257):1861-4 PMID: 8596954
  29. Rapid degradation of the G1 cyclin Cln2 induced by CDK-dependent phosphorylation.
    Science. 1996 Mar 15;271(5255):1597-601 PMID: 8599119
  30. Linkage of replication to start by the Cdk inhibitor Sic1.
    Science. 1996 Apr 26;272(5261):560-2 PMID: 8614808
  31. Nuclear localization signals of human and Thermoplasma proteasomal alpha subunits are functional in vitro.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12060-4 PMID: 8618844
  32. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
    Cell. 1996 May 31;85(5):721-32 PMID: 8646780
  33. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases.
    Nature. 1996 Jun 27;381(6585):804-6 PMID: 8657286
  34. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.
    Cell. 1996 Jul 26;86(2):263-74 PMID: 8706131
  35. The cyclin-dependent kinase inhibitor p40SIC1 imposes the requirement for Cln G1 cyclin function at Start.
    Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7772-6 PMID: 8755551
  36. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Genes Dev. 1996 Aug 15;10(16):1979-90 PMID: 8769642
  37. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Cell Growth Differ. 1996 Feb;7(2):135-46 PMID: 8822197
  38. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E.
    EMBO J. 1996 Aug 15;15(16):4182-93 PMID: 8861947
  39. Cell cycle control by Xenopus p28Kix1, a developmentally regulated inhibitor of cyclin-dependent kinases.
    Mol Biol Cell. 1996 Mar;7(3):457-69 PMID: 8868473
  40. Proteasomes: destruction as a programme.
    Trends Biochem Sci. 1996 Mar;21(3):96-102 PMID: 8882582
  41. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.
    EMBO J. 1996 Oct 1;15(19):5280-9 PMID: 8895573
  42. How proteolysis drives the cell cycle.
    Science. 1996 Dec 6;274(5293):1652-9 PMID: 8939846
  43. Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins.
    Mol Cell Biol. 1996 Dec;16(12):6634-43 PMID: 8943317
  44. Ubiquitin-dependent protein degradation.
    Annu Rev Genet. 1996;30:405-39 PMID: 8982460
  45. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.
    J Biol Chem. 1997 Mar 14;272(11):7093-8 PMID: 9054402
  46. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Genes Dev. 1997 Apr 15;11(8):957-72 PMID: 9136925
  47. Cyclin E-CDK2 is a regulator of p27Kip1.
    Genes Dev. 1997 Jun 1;11(11):1464-78 PMID: 9192873
  48. Import of human and Thermoplasma 20S proteasomes into nuclei of HeLa cells requires functional NLS sequences.
    Eur J Cell Biol. 1997 Jun;73(2):105-13 PMID: 9208223
  49. Proteolysis and DNA replication: the CDC34 requirement in the Xenopus egg cell cycle.
    Science. 1997 Sep 12;277(5332):1672-6 PMID: 9287222
  50. Initiation of cyclin B degradation by the 26S proteasome upon egg activation.
    J Cell Biol. 1997 Sep 22;138(6):1313-22 PMID: 9298986
  51. Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1.
    Genes Dev. 1997 Sep 15;11(18):2335-46 PMID: 9308962
  52. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    EMBO J. 1997 Sep 1;16(17):5334-44 PMID: 9311993
  53. Ubiquitin lys63 is involved in ubiquitination of a yeast plasma membrane protein.
    EMBO J. 1997 Oct 1;16(19):5847-54 PMID: 9312043
  54. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    J Biol Chem. 1997 Oct 10;272(41):25863-72 PMID: 9325318
  55. Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase.
    Science. 1997 Oct 17;278(5337):455-60 PMID: 9334303
  56. Eliminating all obstacles: regulated proteolysis in the eukaryotic cell cycle.
    Cell. 1997 Oct 17;91(2):149-51 PMID: 9346231
  57. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex.
    Cell. 1997 Oct 17;91(2):209-19 PMID: 9346238
  58. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p.
    Cell. 1997 Oct 17;91(2):221-30 PMID: 9346239
  59. The ubiquitin system.
    Trends Biochem Sci. 1997 Oct;22(10):383-7 PMID: 9357313
  60. Targeting of substrates to the 26S proteasome.
    FASEB J. 1997 Nov;11(13):1055-66 PMID: 9367341
  61. Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast.
    Genes Dev. 1997 Nov 15;11(22):3046-60 PMID: 9367986
  62. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1091-6 PMID: 9448290
  63. The proteasome: paradigm of a self-compartmentalizing protease.
    Cell. 1998 Feb 6;92(3):367-80 PMID: 9476896
  64. Proteolysis and the G1-S transition: the SCF connection.
    Curr Opin Genet Dev. 1998 Feb;8(1):36-42 PMID: 9529603
  65. Chemical inhibitors of cyclin-dependent kinases.
    Prog Cell Cycle Res. 1995;1:351-63 PMID: 9552377
  66. Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis.
    Trends Genet. 1998 Jun;14(6):236-43 PMID: 9635407
  67. p21WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression.
    J Cell Sci. 1998 Aug;111 ( Pt 15):2247-55 PMID: 9664046
  68. The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa->luteal transition.
    Cell Growth Differ. 1998 Sep;9(9):787-94 PMID: 9751122
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1999-02-00
Pages
1190-201
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC116048
Subset
IM
Grants
NCI NIH HHS · CA68425 · United States
NIGMS NIH HHS · GM52597 · United States
NCI NIH HHS · CA08748 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]